Literature DB >> 2900890

Naloxone excites oxytocin neurones in the supraoptic nucleus of lactating rats after chronic morphine treatment.

R J Bicknell1, G Leng, D W Lincoln, J A Russell.   

Abstract

1. Lactating rats were implanted with a cannula in a lateral cerebral ventricle to deliver morphine (up to 50 micrograms/h) chronically from a subcutaneous osmotically driven mini-pump. After infusion of morphine for 5 days the rats were anaesthetized with urethane and prepared with ventral surgery for recording the electrical activity of single, antidromically identified neurones in the supraoptic nucleus. 2. A single I.V. injection of naloxone (5 mg/kg) in these rats provoked a long-lasting, large increase in intramammary pressure, but in control rats had negligible effects. Concentrations in plasma of oxytocin, measured by radioimmunoassay in samples of femoral arterial blood, rose from 44.7 +/- 2.5 to 1072.1 +/- 89.5 pg/ml (means +/- S.E.M.) 6 min after naloxone in the morphine-treated rats. In control rats, the concentration of oxytocin in plasma rose only from 42.1 +/- 2.9 to 125.1 +/- 28.2 pg/ml after naloxone. 3. Naloxone produced a transient increase in arterial blood pressure in morphine-treated but not control rats. Concentrations in plasma of vasopressin, measured by radioimmunoassay in samples of femoral arterial blood, rose in morphine-treated rats from 7.4 +/- 2.4 to 29.2 +/- 3.7 pg/ml after naloxone, but did not rise significantly in control rats. 4. Naloxone (1-5 mg/kg) produced a prompt and prolonged increase in the discharge rate of each of ten continuously active (putative oxytocin) cells recorded from ten morphine-treated rats. The discharge rate of the six cells tested at the highest dose (5 mg/kg) increased by an average of 6.3 Hz (360%) within 5 min, and the firing rate remained elevated for at least 30 min; the discharge rate of six continuously active supraoptic neurones recorded in control rats was not affected by naloxone. 5. The firing activity of five phasic (putative vasopressin) supraoptic neurones in morphine-treated rats was increased for at least 30 min by the injection of naloxone; these increases were the result of a raised intraburst firing rate with no change in burst duration or frequency. One phasic neurone was inhibited for 15 min, and one phasic neurone was unaffected. 6. The excitatory effects of naloxone on neurones in the supraoptic nucleus of morphine-treated rats were not explained by changes in blood pressure or osmolarity and did not depend on suckling or a cholinergic pathway. 7. The concentrations of oxytocin in plasma and the operation of the milk-ejection reflex were similar in the controls and morphine-treated rats, prior to naloxone. These findings indicate tolerance to initial inhibitory effects of morphine on oxytocin secretion.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900890      PMCID: PMC1192046          DOI: 10.1113/jphysiol.1988.sp016963

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  51 in total

1.  Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine.

Authors:  G K Aghajanian
Journal:  Nature       Date:  1978-11-09       Impact factor: 49.962

2.  Oxytocin release following osmotic activation of oxytocin neurones in the paraventricular and supraoptic nuclei.

Authors:  M J Brimble; R E Dyball; M L Forsling
Journal:  J Physiol       Date:  1978-05       Impact factor: 5.182

3.  Cellular site of opiate dependence.

Authors:  H O Collier
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

4.  A highly specific antiserum for arginine vasopressin.

Authors:  G Moore; A Lutterodt; G Burford; K Lederis
Journal:  Endocrinology       Date:  1977-11       Impact factor: 4.736

5.  Antidiuretic effect of morphine and vasopressin in morphine tolerant and non-tolerant rats, differential effects on urine composition.

Authors:  F Huidobro; J Huidobro-Toro
Journal:  Eur J Pharmacol       Date:  1979-10-26       Impact factor: 4.432

6.  Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones.

Authors:  G Clarke; P Wood; L Merrick; D W Lincoln
Journal:  Nature       Date:  1979-12-13       Impact factor: 49.962

7.  Effects of cholinoceptor antagonists on the suckling-induced and experimentally evoked release of oxytocin.

Authors:  G Clarke; C H Fall; D W Lincoln; L P Merrick
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

8.  Endogenous opiates regulate oxytocin but not vasopressin secretion from the neurohypophysis.

Authors:  R J Bicknell; G Leng
Journal:  Nature       Date:  1982-07-08       Impact factor: 49.962

9.  Effects of chemoreceptor and baroreceptor stimulation on the discharge of hypothalamic supraoptic neurones in rats.

Authors:  M C Harris
Journal:  J Endocrinol       Date:  1979-07       Impact factor: 4.286

10.  Phasic firing enhances vasopressin release from the rat neurohypophysis.

Authors:  A Dutton; R E Dyball
Journal:  J Physiol       Date:  1979-05       Impact factor: 5.182

View more
  22 in total

1.  Does oxytocin deficiency mediate social deficits in autism?

Authors:  C Modahl; D Fein; L Waterhouse; N Newton
Journal:  J Autism Dev Disord       Date:  1992-09

2.  Differential modulation of N-type calcium channels by micro-opioid receptors in oxytocinergic versus vasopressinergic neurohypophysial terminals.

Authors:  Sonia I Ortiz-Miranda; Govindan Dayanithi; Cristina Velázquez-Marrero; Edward E Custer; Steven N Treistman; José R Lemos
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

3.  Activation of oxytocin neurones by systemic cholecystokinin is unchanged by morphine dependence or withdrawal excitation in the rat.

Authors:  C H Brown; G Munro; N P Murphy; G Leng; J A Russell
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

4.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

5.  Apamin increases post-spike excitability of supraoptic nucleus neurons in anaesthetized morphine-naïve rats and morphine-dependent rats: consequences for morphine withdrawal excitation.

Authors:  Philip M Bull; John A Russell; Victoria Scott; Colin H Brown
Journal:  Exp Brain Res       Date:  2011-06-14       Impact factor: 1.972

6.  Local morphine withdrawal increases c-fos gene, Fos protein, and oxytocin gene expression in hypothalamic magnocellular neurosecretory cells.

Authors:  L E Johnstone; C H Brown; H K Meeren; C L Vuijst; P J Brooks; G Leng; J A Russell
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

Review 7.  Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.

Authors:  Mary R Lee; Matthew C H Rohn; Gianluigi Tanda; Lorenzo Leggio
Journal:  CNS Drugs       Date:  2016-02       Impact factor: 5.749

8.  Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat.

Authors:  S L Lightman; W S Young
Journal:  J Physiol       Date:  1988-09       Impact factor: 5.182

9.  Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.

Authors:  J A Russell; J E Coombes; G Leng; R J Bicknell
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

10.  Effects of the selective kappa-opioid agonist U50,488 upon the electrical activity of supraoptic neurones in morphine-tolerant and morphine-naive rats.

Authors:  K M Pumford; J A Russell; G Leng
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.